FSSAI Assessing WHO's New Guideline on Non-Sugar Sweeteners and Potential Health Risks

The Food Safety and Standards Authority of India (FSSAI) has announced that it is currently evaluating the recently issued guideline by the World Health Organization (WHO) concerning non-sugar sweeteners, such as aspartame and stevia. The WHO guideline states that these sweeteners do not contribute to weight loss and may even increase the risk of type 2 diabetes and cardiovascular diseases.

Large Indian brands of soft drinks, breakfast cereals, ice creams, and juices frequently employ non-sugar sweeteners as supposed "healthy" substitutes for sugar. However, with the emergence of the WHO guideline, concerns have been raised about using these sweeteners and their impact on public health.

In response, the FSSAI recognized the importance of thoroughly assessing the potential implications and effects of the guideline on the Indian context. The FSSAI's evaluation aims to comprehensively understand the scientific basis and potential consequences outlined in the WHO guideline. By conducting a thorough analysis, the FSSAI intends to make informed decisions regarding the regulation and guidelines surrounding non-sugar sweeteners in India.

A spokesperson from FSSAI stated that "the extensive use of non-sugar sweeteners by prominent Indian brands underscores the significance of this evaluation, and it is crucial for regulatory authorities, manufacturers, and consumers to stay updated on the evolving scientific evidence and potential health risks associated with non-sugar sweeteners."

The objective of the revised guidelines is to provide consumers with more precise information about the potential health implications of consuming products containing non-sugar sweeteners. By implementing stricter labeling regulations, the FSSAI aims to empower individuals to make informed choices regarding their dietary preferences, particularly concerning their sugar intake.

The FSSAI's assessment of the WHO guideline reflects its commitment to ensuring the safety and well-being of consumers in India. The outcomes of this evaluation will play a crucial role in shaping future policies and regulations concerning the use of non-sugar sweeteners, ultimately impacting the choices available to consumers in the Indian food and beverage market.


Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks